Urgent cancer warning over popular tanning product: 'It's dangerous', say experts
The unregulated sprays–which claim to accelerate tanning–may also trigger nausea, vomiting, and high blood pressure according to the Chartered Trading Standards Institute (CTSI).
The CTSI is now urging the public to avoid any tanning product that is 'inhaled or ingested'.
The sprays claim to work by delivering a substance known as Melanotan 2, a chemical that darkens skin pigmentation and which is banned in the UK.
While this creates a tan it 'may also encourage abnormal skin cell changes in response to UV exposure', according to the Melanoma Fund.
It's these changes that can potentially lead to melanoma, the deadliest form of skin cancer.
However, as the sprays are marketed as a cosmetic product rather than a medicine they are not as tightly regulated and have surged in popularity.
According to the British Beauty Council, the self-tan market is set to hit £746.3 million by 2027.
The CTSI also raised the alarm on the growing trend of people using flavoured nasal tanning sprays, drops and gummies.
They warned that 'unscrupulous' sellers on Facebook and TikTok were posting pictures of the products available in child-friendly flavours such as peach, bubblegum, grape, strawberry and lime.
The regulator said it feared they could become the latest 'must have' products among young people 'leading to a youth epidemic as we saw with disposable vapes'.
Susanna Daniels, chief executive of the skin-cancer charity Melanoma Focus, said: 'We're becoming increasingly concerned about the use of both nasal tanning sprays and tanning injections and their potential links with melanoma skin cancer.
'These unregulated and illegal products not only pose serious health risks but also encourage harmful behaviours, particularly among young consumers.
'We urge the public to consider the long-term impacts on their health and avoid using these substances altogether.'
Gary Lipman, chairman at the Sunbed Association, added: 'Nasal sprays have absolutely no place in a professional tanning salon.
'We fully support CTSI's campaign to heighten awareness of the dangers of using them.'
Some British patients have already been harmed by the products.
Jen Atkin, a former Miss Great Britain winner from Grimsby, Lincolnshire, said she has been permanently scarred after using a nasal tanning spray she bought on Instagram.
'Unfortunately, I decided to go to extra lengths and fell into the trend of nasal tan,' she said.
Ms Atkin used the £25 product twice and a dark brown mark appeared 'out of absolutely nowhere' on her forehead.
She added: 'It scared the life out of me. It made me feel so nauseous and weird.'
Melanoma is a serious form of skin cancer that begins in melanocytes, cells found in the upper layer of skin that produce melanin, which gives skin its colour.
While less common than other types of skin cancer, it is more dangerous because of its ability to spread to other organs more rapidly if it is not treated at an early stage.
Around 17,000 people are diagnosed with melanoma each year, according to the latest figures published on the Cancer Research UK website.
There is an annual average of 2,300 deaths from the skin cancer, according to the charity, with it accounting for around 1 per cent of cancer deaths.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
18 minutes ago
- Sky News
BMA hits back at claims it refused to allow doctors to work in critical areas during strike
The British Medical Association has hit back at claims the organisation refused to allow doctors to keep working in critical areas during five days of strike action. Resident doctors – previously known as junior doctors – began a five day strike across England on Friday as part of an escalating row between NHS bosses and the BMA over pay. The strike ended at 7am this morning (Wednesday). During a strike, NHS trusts can apply for measures, often called "derogations", which would allow doctors to return to work providing critical services when it is feared patient safety is at risk. In an update to staff on Tuesday morning, Sir James Mackey, chief executive of the NHS, said 18 requests for patient safety mitigations (derogations) had been turned down. Sir Jim claimed that in nine of the 18 cases, the BMA said it would allow doctors to return to work, but only if they were paid "extortionate" rates. "Unfortunately, despite all requests being made and verified by senior medics, 18 have been rejected by the BMA, with half of those rejections saying the BMA would support only if extortionate pay rates were offered to striking doctors," Sir James said. But a spokesperson for the BMA told Sky News the claims by Sir James were "untrue and unfounded". "When a derogation is agreed between the BMA and NHS England and which requires a resident doctor to return to work, they do not receive any kind of enhanced payment because those resident doctors are going back to their ward or department to do their usual work," they said. 1:16 "Sir James is clearly quite confused about the derogation process if he is suggesting anything different." 'Wholly wrong and untrue' The BMA said before any derogation is granted, a trust is expected to demonstrate it has "done everything possible to incentivise non-striking doctors to cover the vacant shifts". "This can include paying enhanced rates of pay and this is a usual practice when asking doctors to take on extra-contractual work, over and above their normal hours and is not exclusive to covering gaps that trusts have failed to adequately plan for during industrial action." They said the claim that the BMA requires increased payments to striking doctors is "wholly wrong and Sir James Mackey should withdraw these comments and apologise for the misleading impression they are creating". Fewer patients were affected by the five-day walkout compared to previous strikes, NHS officials said this morning, with fewer doctors taking to picket lines. The number of appointments, procedures and operations that were postponed are expected to be published later this week. But as this week's strike comes to an end, the union is not ruling out further strikes. Health Secretary Wes Streeting has said future talks could lead to improvements in the working lives of resident doctors but he has repeatedly said there is no more money for pay. But BMA leaders have insisted there must be some discussion around pay. Last July, resident doctors were awarded a raise of 22% over two years, the highest public sector award in recent years. But the BMA has argued that pay has declined significantly since 2008, and are calling for a rise of 29.2% to reverse "pay erosion".
The Independent
38 minutes ago
- The Independent
196 people fell sick during E coli outbreak linked to salad
Health officials have revealed there was a 26 per cent surge in shiga toxin E coli (STEC) infections in 2024, reaching 2,544 cases, partly driven by an outbreak linked to salad. The outbreak resulted in two deaths, 196 cases, and 126 hospitalisations. Major supermarkets and food manufacturers recalled numerous sandwich, wrap, and salad products in June 2024 due to contamination fears. Of the total cases in 2024, there were seven deaths, and children aged 1 to 4 years were disproportionately affected. UKHSA and the Food Standards Agency are collaborating to understand the reasons behind the rise in STEC cases and implement public health protection measures.
Medical News Today
43 minutes ago
- Medical News Today
Dementia may take 3.5 years to diagnose after symptoms begin, but why?
Dementia is a hard disease to diagnose for a number of reasons.A new study has found that people who have dementia are, on average, diagnosed 3.5 years after symptoms first appear. This is even longer — an average of 4.1 years after symptoms first show — for people with early onset dementia. According to the World Health Organization (WHO), about 57 million people around the world in 2021 were living with dementia — an umbrella term for a group of conditions that impact a person's memory and ability to think and communicate, such as Alzheimer's disease. Dementia is a hard disease to diagnose. There is currently no single test to diagnose the condition, and symptoms of dementia are very similar to those of other diseases. Additionally, for some people, their dementia symptoms are very subtle in the early stage of the disease, making it hard for a doctor to make a complete diagnosis. Over the last few years, researchers have been focusing on finding new ways to help doctors detect and diagnose dementia as early as possible. 'Timely diagnosis of dementia is crucial for several reasons,' Vasiliki Orgeta, PhD, associate professor in the Division of Psychiatry, Faculty of Brain Sciences at University College London, explained to Medical News Today. 'First and foremost, early detection empowers individuals and their families to plan ahead, and make informed decisions about their care.' 'From a healthcare perspective, timely diagnosis reduces the strain on healthcare systems by enabling proactive rather than reactive care,' she continued. 'As our global population ages, the prevalence of dementia is rising sharply. Timely diagnosis, therefore, is key to addressing this growing public health challenge.' Orgeta is the lead author of a new study recently published in the International Journal of Geriatric Psychiatry that reports people who have dementia are, on average, diagnosed 3.5 years after symptoms first appear. This is even longer — an average of 4.1 years after symptoms first show — for people with early onset dementia. The time between symptoms and dementia diagnosisFor this study, researchers analyzed the results of 13 previously published studies, encompassing more than 30,000 participants. Scientists focused on the average time span between when symptoms were first noticed by patients or their family members, to their dementia diagnosis. 'We decided to examine the average interval between symptom onset and final diagnosis of dementia because this timeframe has significant implications for patient outcomes, families, and the overall healthcare system,' Orgeta said. 'Despite increasing awareness, many individuals still face delays of months or even years before receiving a formal diagnosis,' she said. 3.5 years for a dementia diagnosis once symptoms beginAt the study's conclusion, researchers found that dementia diagnosis occurs, on average, about 3.5 years after symptoms begin to show. This timespan average jumped to 4.1 years for participants with early onset dementia. 'The finding that it typically takes 3.5 years to receive a dementia diagnosis — and even longer, 4.1 years, for those with early-onset dementia — highlights a critical delay in the diagnostic journey, during which individuals and their families may be living with uncertainty, and without access to the support and planning resources they need.'— Vasiliki Orgeta, PhD'These findings underscore the urgent need to improve public awareness, enhance training for healthcare providers, and streamline referral pathways,' Orgeta said. Younger age, frontotemporal dementia linked to longer diagnosis timeOrgeta and her team also discovered that participants with a younger age at symptom onset and those diagnosed with frontotemporal dementia correlated with a longer diagnosis time. 'These delays mean that many younger individuals are left without the clarity, support, or medical care they need for years,' Orgeta said. 'Our findings emphasize the need for greater awareness and education among healthcare professionals to recognize the early signs of less common dementias, particularly in younger populations. Improving early detection in these groups is essential to ensure timely support, reduce misdiagnoses, and improve long-term outcomes.' 'We plan to work closely with people affected by dementia and their families, clinicians and policymakers to develop strategies that support earlier identification and more efficient diagnostic pathways — particularly for younger individuals and those with less common forms of dementia like frontotemporal dementia,' she added. What causes a delay in dementia diagnosis? MNT also spoke with Adel Aziz, MD, FAAN, cognitive and behavioral neurologist, assistant professor of neurology at Hackensack Meridian School of Medicine, and memory specialist at JFK University Medical Center, about this study. 'I would like to stress that experienced clinicians rarely find the concept of delayed dementia diagnosis surprising,' Aziz commented. 'What this meta-analysis adds is a shared language — 'Time To Diagnose (TTD)' — and empirical weights for each contributing factor. By translating anecdotes into measurable variables, it empowers specialists to benchmark performance, tailor interventions, and advocate for policy change.' Aziz explained that delays in diagnosing dementia arise at multiple points: when patients and families postpone seeking help, when primary providers hesitate to refer, and when early cognitive symptoms are misattributed to aging or anxiety.'This multifaceted issue intertwines with social determinants like education, socioeconomic status, minority identity, sex, age of symptom onset, dementia subtype, and the strength of a patient's support system,' he help lower the time between first dementia symptoms and formal diagnosis, Aziz said it will require community awareness campaigns to demystify dementia signs across diverse populations, provider education programs to train frontline clinicians on early, atypical dementia presentations, policy and advocacy to advocate for insurance coverage of cognitive assessments, and new technologies such as a telehealth cognitive screening for remote areas. 'With these layers of action — spanning public education, clinical training, policy reform, and technological innovation — we can move toward a future where dementia is recognized and managed as early as possible,' he added.
